The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Influence of facility (Fac) annual caseload (AC) on survival of patients (pts) with respectable urothelial carcinoma (UC) of the bladder.
 
Sarmad Sadeghi
Consulting or Advisory Role - Pfizer
Research Funding - Merck; Pfizer
 
Primo Lara
Honoraria - Pfizer
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Exelixis; Genentech/Roche; Janssen; Novartis; Pfizer; Turnstone Bio
Research Funding - Aragon Pharmaceuticals (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Incyte (Inst); Janssen Biotech (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Polaris (Inst); TRACON Pharma (Inst)
 
Mihir Desai
No Relationships to Disclose
 
Siamak Daneshmand
No Relationships to Disclose
 
David F. Penson
Consulting or Advisory Role - Astellas Pharma; Dendreon; Janssen
Research Funding - Astellas Pharma (Inst)
 
Seth P. Lerner
Consulting or Advisory Role - BioCancell; Incyte; Nucleix; Urogen pharma; Vaxiion
Research Funding - Endo Pharmaceuticals; FKD Therapies; JenaValve; Roche/Genentech; Viventia Biotech
Travel, Accommodations, Expenses - BioCancell; Urogen pharma
 
David I. Quinn
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; EMD Serono; Exelixis; Genentech/Roche; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Eisai; EMD Serono; Exelixis; Genentech/Roche; Janssen Oncology; Merck Sharp & Dohme; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
 
Afsaneh Barzi
Consulting or Advisory Role - bioTheranostics; Merrion